Patient Appropriate High dose rate brachytherapy Prostate
Item
patient must be a candidate for hdr prostate brachytherapy
boolean
C0030705 (UMLS CUI [1,1])
C1548787 (UMLS CUI [1,2])
C0454270 (UMLS CUI [1,3])
C0033572 (UMLS CUI [1,4])
Ability Receive MRI scan
Item
patient must be able to have mr scan
boolean
C0085732 (UMLS CUI [1,1])
C1514756 (UMLS CUI [1,2])
C0024485 (UMLS CUI [1,3])
Lesion of prostate Predominant Visible Magnetic Resonance Spectroscopy
Item
patient must have a visible dil on mrs
boolean
C0577255 (UMLS CUI [1,1])
C1542147 (UMLS CUI [1,2])
C0205379 (UMLS CUI [1,3])
C0024487 (UMLS CUI [1,4])
Informed Consent
Item
patient has signed the protocol consent form
boolean
C0021430 (UMLS CUI [1])
Radiotherapy to pelvis Absent | Radiotherapy to prostate Absent | Prior Chemotherapy Absent
Item
no prior pelvic or prostate radiation or chemotherapy for any reason
boolean
C1536155 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0948317 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C1514457 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
Induction Hormone Therapy | MRI prior to Hormone Therapy | MRS prior to Hormone Therapy
Item
induction hormonal therapy beginning ≤ 120 days prior to study entry is acceptable only if there is a mri/mrs done prior to starting hormonal therapy
boolean
C0600558 (UMLS CUI [1,1])
C0279025 (UMLS CUI [1,2])
C0024485 (UMLS CUI [2,1])
C0332152 (UMLS CUI [2,2])
C0279025 (UMLS CUI [2,3])
C0024487 (UMLS CUI [3,1])
C0332152 (UMLS CUI [3,2])
C0279025 (UMLS CUI [3,3])
Prostate specific antigen measurement
Item
prostate specific antigen prior to any (hormonal) therapy must be ≤ 20 ng/ml
boolean
C0201544 (UMLS CUI [1])
Combination Factor
Item
one of the following combinations of factors:
boolean
C0205195 (UMLS CUI [1,1])
C1521761 (UMLS CUI [1,2])
TNM clinical staging | Gleason score | Prostate specific antigen measurement
Item
clinical stage t2a-2b, gleason score 2-6 and psa ≥ 10 but ≤ 20
boolean
C3258246 (UMLS CUI [1])
C3203027 (UMLS CUI [2])
C0201544 (UMLS CUI [3])
TNM clinical staging | Gleason score | Prostate specific antigen measurement
Item
clinical stage t3a-t3b, gleason score 2-6 and psa ≤ 20
boolean
C3258246 (UMLS CUI [1])
C3203027 (UMLS CUI [2])
C0201544 (UMLS CUI [3])
TNM clinical staging | Gleason score | Prostate specific antigen measurement
Item
clinical stage t2a-t3b, gleason score 7-10 and psa ≤ 20
boolean
C3258246 (UMLS CUI [1])
C3203027 (UMLS CUI [2])
C0201544 (UMLS CUI [3])
Hip prosthesis
Item
patient with hip prosthesis
boolean
C0019560 (UMLS CUI [1])
Artificial cardiac pacemaker
Item
patient with pacemaker
boolean
C0030163 (UMLS CUI [1])
Operation on prostate Radical
Item
patient with history of radical surgery for prostate
boolean
C0194790 (UMLS CUI [1,1])
C0439807 (UMLS CUI [1,2])
Claustrophobia
Item
patient with claustrophobia
boolean
C0008909 (UMLS CUI [1])
Metal Body | At risk Magnetic Resonance Imaging
Item
patient with metal in body not safe for mr
boolean
C0025552 (UMLS CUI [1,1])
C1268086 (UMLS CUI [1,2])
C1444641 (UMLS CUI [2,1])
C0024485 (UMLS CUI [2,2])
Disease TNM clinical staging
Item
stage t4 disease
boolean
C0012634 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
Lymph Node Involvement
Item
lymph node involvement (n1)
boolean
C0806692 (UMLS CUI [1])
Distant metastasis
Item
evidence of distant metastases (m1)
boolean
C1269798 (UMLS CUI [1])
Prior Hormone Therapy
Item
previous hormonal therapy beginning > 120 days prior to registration
boolean
C1514460 (UMLS CUI [1])
Hormone Therapy prior to MRI | Hormone Therapy prior to MRS
Item
hormonal therapy prior to mri/mrs
boolean
C0279025 (UMLS CUI [1,1])
C0332152 (UMLS CUI [1,2])
C0024485 (UMLS CUI [1,3])
C0279025 (UMLS CUI [2,1])
C0332152 (UMLS CUI [2,2])
C0024487 (UMLS CUI [2,3])